Clinical trial
A Phase I Study of Isolated Hepatic Perfusion With Escalating Dose Melphalan…
NCT00001576 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00001576 |
|---|---|
| Title | A Phase I Study of Isolated Hepatic Perfusion With Escalating Dose Melphalan Followed by Postoperative Hepatic Arterial Floxuridine and Leucovorin for Metastatic Unresectable Colorectal Cancers of the Liver |
| Official title | A Phase I Study of Isolated Hepatic Perfusion With Escalating Dose Melphalan Followed by Postoperative Hepatic Arterial Floxuridine and Leucovorin for Metastatic Unresectable Colorectal Cancers of the Liver |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Colorectal Neoplasm, Liver Neoplasm, Neoplasm Metastasis |
| Intervention type | Drug |
| Interventions | Melphalan, Floxuridine, Leucovorin |
| Enrollment | 28 |
| Start date | Jul 1, 1997 |
| Completion | Mar 1, 2002 |
| First posted | Nov 4, 1999 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: